Hyperglucagonaemia and treatment with danazol for systemic lupus erythematosus.
article
OA: bronze
CC0
⤵ 5 in-corpus citations
AI-generated summary
This paper investigated hyperglucagonemia in systemic lupus erythematosus patients and assessed the efficacy of danazol treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (7)
- Systemic lupus erythematosus: two patients treated with danazol via openalex
- The Effect of Danazol on Anterior Pituitary Function via openalex
- W2460430351 via openalex
- doi:10.1016/0009-8981(77)90240-6 via openalex
- doi:10.1136/jcp.25.3.266 via openalex
- W2415888241 via openalex
- W97811737 via openalex
Cited by (5)
- Effect of danazol‐induced chronic hyperglucagonaemia on glucose tolerance and turnover 1995
- Metabolie effects of danazol 1991
- Glucose tolerance and insulin resistance after danazol treatment 1989
- The treatment of glucocorticosteroid-dependent chronic urticaria with stanozolol 1988
- Elevated plasma glucagon caused by danazol 1987
Source provenance
- openalex
- last seen: 2026-05-11T05:08:23.114259+00:00
License: CC0
· commercial use OK